Nonviral gene editing via CRISPR/Cas9 delivery by membrane-disruptive and endosomolytic helical polypeptide

Hong Xia Wang, Ziyuan Song, Yeh Hsing Lao, Xin Xu, Jing Gong, Du Cheng, Syandan Chakraborty, Ji Sun Park, Mingqiang Li, Dantong Huang, Lichen Yin, Jianjun Cheng, Kam W. Leong

Research output: Contribution to journalArticle

Abstract

Effective and safe delivery of the CRISPR/Cas9 gene-editing elements remains a challenge. Here we report the development of PEGylated nanoparticles (named P-HNPs) based on the cationic α-helical polypeptide poly(γ-4-((2-(piperidin-1-yl)ethyl)aminomethyl)benzyl-L-glu-tamate) for the delivery of Cas9 expression plasmid and sgRNA to various cell types and gene-editing scenarios. The cell-penetrating α-helical polypeptide enhanced cellular uptake and promoted escape of pCas9 and/or sgRNA from the endosome and transport into the nucleus. The colloidally stable P-HNPs achieved a Cas9 transfection efficiency up to 60% and sgRNA uptake efficiency of 67.4%, representing an improvement over existing polycation-based gene delivery systems. After performing single or multiplex gene editing with an efficiency up to 47.3% in vitro, we demonstrated that P-HNPs delivering Cas9 plasmid/sgRNA targeting the polo-like kinase 1 (Plk1) gene achieved 35% gene deletion in HeLa tumor tissue to reduce the Plk1 protein level by 66.7%, thereby suppressing the tumor growth by >71% and prolonging the animal survival rate to 60% within 60 days. Capable of delivering Cas9 plasmids to various cell types to achieve multiplex gene knock-out, gene knock-in, and gene activation in vitro and in vivo, the P-HNP system offers a versatile gene-editing platform for biological research and therapeutic applications.

Original languageEnglish (US)
Pages (from-to)4903-4908
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume115
Issue number19
DOIs
StatePublished - May 8 2018

Fingerprint

Clustered Regularly Interspaced Short Palindromic Repeats
Peptides
Plasmids
Membranes
Gene Knock-In Techniques
Therapeutic Human Experimentation
Gene Transfer Techniques
Gene Knockout Techniques
Endosomes
Gene Deletion
Nanoparticles
Transcriptional Activation
Transfection
Neoplasms
Gene Editing
Growth
Genes
Proteins

Keywords

  • CRISPR/Cas9
  • Cell-penetrating peptide
  • Genome editing
  • Helical polypeptide
  • Nanomedicine

ASJC Scopus subject areas

  • General

Cite this

Nonviral gene editing via CRISPR/Cas9 delivery by membrane-disruptive and endosomolytic helical polypeptide. / Wang, Hong Xia; Song, Ziyuan; Lao, Yeh Hsing; Xu, Xin; Gong, Jing; Cheng, Du; Chakraborty, Syandan; Park, Ji Sun; Li, Mingqiang; Huang, Dantong; Yin, Lichen; Cheng, Jianjun; Leong, Kam W.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 115, No. 19, 08.05.2018, p. 4903-4908.

Research output: Contribution to journalArticle

Wang, HX, Song, Z, Lao, YH, Xu, X, Gong, J, Cheng, D, Chakraborty, S, Park, JS, Li, M, Huang, D, Yin, L, Cheng, J & Leong, KW 2018, 'Nonviral gene editing via CRISPR/Cas9 delivery by membrane-disruptive and endosomolytic helical polypeptide', Proceedings of the National Academy of Sciences of the United States of America, vol. 115, no. 19, pp. 4903-4908. https://doi.org/10.1073/pnas.1712963115
Wang, Hong Xia ; Song, Ziyuan ; Lao, Yeh Hsing ; Xu, Xin ; Gong, Jing ; Cheng, Du ; Chakraborty, Syandan ; Park, Ji Sun ; Li, Mingqiang ; Huang, Dantong ; Yin, Lichen ; Cheng, Jianjun ; Leong, Kam W. / Nonviral gene editing via CRISPR/Cas9 delivery by membrane-disruptive and endosomolytic helical polypeptide. In: Proceedings of the National Academy of Sciences of the United States of America. 2018 ; Vol. 115, No. 19. pp. 4903-4908.
@article{cdfc74e067df4c3e9703540c3321e703,
title = "Nonviral gene editing via CRISPR/Cas9 delivery by membrane-disruptive and endosomolytic helical polypeptide",
abstract = "Effective and safe delivery of the CRISPR/Cas9 gene-editing elements remains a challenge. Here we report the development of PEGylated nanoparticles (named P-HNPs) based on the cationic α-helical polypeptide poly(γ-4-((2-(piperidin-1-yl)ethyl)aminomethyl)benzyl-L-glu-tamate) for the delivery of Cas9 expression plasmid and sgRNA to various cell types and gene-editing scenarios. The cell-penetrating α-helical polypeptide enhanced cellular uptake and promoted escape of pCas9 and/or sgRNA from the endosome and transport into the nucleus. The colloidally stable P-HNPs achieved a Cas9 transfection efficiency up to 60{\%} and sgRNA uptake efficiency of 67.4{\%}, representing an improvement over existing polycation-based gene delivery systems. After performing single or multiplex gene editing with an efficiency up to 47.3{\%} in vitro, we demonstrated that P-HNPs delivering Cas9 plasmid/sgRNA targeting the polo-like kinase 1 (Plk1) gene achieved 35{\%} gene deletion in HeLa tumor tissue to reduce the Plk1 protein level by 66.7{\%}, thereby suppressing the tumor growth by >71{\%} and prolonging the animal survival rate to 60{\%} within 60 days. Capable of delivering Cas9 plasmids to various cell types to achieve multiplex gene knock-out, gene knock-in, and gene activation in vitro and in vivo, the P-HNP system offers a versatile gene-editing platform for biological research and therapeutic applications.",
keywords = "CRISPR/Cas9, Cell-penetrating peptide, Genome editing, Helical polypeptide, Nanomedicine",
author = "Wang, {Hong Xia} and Ziyuan Song and Lao, {Yeh Hsing} and Xin Xu and Jing Gong and Du Cheng and Syandan Chakraborty and Park, {Ji Sun} and Mingqiang Li and Dantong Huang and Lichen Yin and Jianjun Cheng and Leong, {Kam W.}",
year = "2018",
month = "5",
day = "8",
doi = "10.1073/pnas.1712963115",
language = "English (US)",
volume = "115",
pages = "4903--4908",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "19",

}

TY - JOUR

T1 - Nonviral gene editing via CRISPR/Cas9 delivery by membrane-disruptive and endosomolytic helical polypeptide

AU - Wang, Hong Xia

AU - Song, Ziyuan

AU - Lao, Yeh Hsing

AU - Xu, Xin

AU - Gong, Jing

AU - Cheng, Du

AU - Chakraborty, Syandan

AU - Park, Ji Sun

AU - Li, Mingqiang

AU - Huang, Dantong

AU - Yin, Lichen

AU - Cheng, Jianjun

AU - Leong, Kam W.

PY - 2018/5/8

Y1 - 2018/5/8

N2 - Effective and safe delivery of the CRISPR/Cas9 gene-editing elements remains a challenge. Here we report the development of PEGylated nanoparticles (named P-HNPs) based on the cationic α-helical polypeptide poly(γ-4-((2-(piperidin-1-yl)ethyl)aminomethyl)benzyl-L-glu-tamate) for the delivery of Cas9 expression plasmid and sgRNA to various cell types and gene-editing scenarios. The cell-penetrating α-helical polypeptide enhanced cellular uptake and promoted escape of pCas9 and/or sgRNA from the endosome and transport into the nucleus. The colloidally stable P-HNPs achieved a Cas9 transfection efficiency up to 60% and sgRNA uptake efficiency of 67.4%, representing an improvement over existing polycation-based gene delivery systems. After performing single or multiplex gene editing with an efficiency up to 47.3% in vitro, we demonstrated that P-HNPs delivering Cas9 plasmid/sgRNA targeting the polo-like kinase 1 (Plk1) gene achieved 35% gene deletion in HeLa tumor tissue to reduce the Plk1 protein level by 66.7%, thereby suppressing the tumor growth by >71% and prolonging the animal survival rate to 60% within 60 days. Capable of delivering Cas9 plasmids to various cell types to achieve multiplex gene knock-out, gene knock-in, and gene activation in vitro and in vivo, the P-HNP system offers a versatile gene-editing platform for biological research and therapeutic applications.

AB - Effective and safe delivery of the CRISPR/Cas9 gene-editing elements remains a challenge. Here we report the development of PEGylated nanoparticles (named P-HNPs) based on the cationic α-helical polypeptide poly(γ-4-((2-(piperidin-1-yl)ethyl)aminomethyl)benzyl-L-glu-tamate) for the delivery of Cas9 expression plasmid and sgRNA to various cell types and gene-editing scenarios. The cell-penetrating α-helical polypeptide enhanced cellular uptake and promoted escape of pCas9 and/or sgRNA from the endosome and transport into the nucleus. The colloidally stable P-HNPs achieved a Cas9 transfection efficiency up to 60% and sgRNA uptake efficiency of 67.4%, representing an improvement over existing polycation-based gene delivery systems. After performing single or multiplex gene editing with an efficiency up to 47.3% in vitro, we demonstrated that P-HNPs delivering Cas9 plasmid/sgRNA targeting the polo-like kinase 1 (Plk1) gene achieved 35% gene deletion in HeLa tumor tissue to reduce the Plk1 protein level by 66.7%, thereby suppressing the tumor growth by >71% and prolonging the animal survival rate to 60% within 60 days. Capable of delivering Cas9 plasmids to various cell types to achieve multiplex gene knock-out, gene knock-in, and gene activation in vitro and in vivo, the P-HNP system offers a versatile gene-editing platform for biological research and therapeutic applications.

KW - CRISPR/Cas9

KW - Cell-penetrating peptide

KW - Genome editing

KW - Helical polypeptide

KW - Nanomedicine

UR - http://www.scopus.com/inward/record.url?scp=85046681279&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046681279&partnerID=8YFLogxK

U2 - 10.1073/pnas.1712963115

DO - 10.1073/pnas.1712963115

M3 - Article

C2 - 29686087

AN - SCOPUS:85046681279

VL - 115

SP - 4903

EP - 4908

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 19

ER -